Oscar Health, Inc. (NYSE:OSCR) Receives $20.21 Average PT from Analysts

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has received an average recommendation of "Hold" from the eight brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is $20.21.

Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th.

Institutional Trading of Oscar Health

Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock valued at $255,333,000 after acquiring an additional 586,626 shares in the last quarter. Deerfield Management Company L.P. Series C raised its position in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. Thrive Capital Management LLC grew its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its holdings in shares of Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Oscar Health Price Performance

NYSE:OSCR traded up $0.22 during trading hours on Tuesday, reaching $12.25. 3,593,852 shares of the company were exchanged, compared to its average volume of 3,893,885. The business has a 50 day moving average of $13.56 and a 200 day moving average of $14.82. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market capitalization of $3.07 billion, a P/E ratio of -612.19 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Research analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.